Walgreens Boots Alliance (NASDAQ:WBA) Releases Quarterly Earnings Results, Beats Expectations By $0.13 EPS

Walgreens Boots Alliance (NASDAQ:WBA) issued its earnings results on Friday. The pharmacy operator reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13, RTT News reports. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same period in the prior year, the company posted $0.66 earnings per share. Walgreens Boots Alliance’s revenue was up 7.6% on a year-over-year basis. Walgreens Boots Alliance updated its FY 2025 guidance to 1.400-1.800 EPS and its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Trading Up 27.5 %

Shares of NASDAQ WBA opened at $11.76 on Friday. Walgreens Boots Alliance has a fifty-two week low of $8.08 and a fifty-two week high of $24.93. The firm has a market capitalization of $10.15 billion, a P/E ratio of -1.17, a P/E/G ratio of 1.36 and a beta of 0.64. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. The company’s 50 day simple moving average is $9.26 and its 200 day simple moving average is $9.85.

Walgreens Boots Alliance Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were given a dividend of $0.25 per share. The ex-dividend date was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 8.50%. Walgreens Boots Alliance’s payout ratio is presently -9.99%.

Analysts Set New Price Targets

A number of research firms have weighed in on WBA. TD Cowen decreased their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Jefferies Financial Group dropped their price objective on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Barclays boosted their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. Evercore ISI lifted their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research note on Wednesday, October 16th. Finally, Royal Bank of Canada dropped their price target on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a report on Wednesday, December 4th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $12.58.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.